Nader Rahimi

Dr. Nader Rahimi is an Associate Professor at Boston University's Chobanian & Avedisian School of Medicine, addressing critical issues in the field of pathology and laboratory medicine. With a Ph.D. from Queen's University, Dr. Rahimi's research expertise is centered on cell signaling, with a particular focus on receptor tyrosine kinases and protein modifications. His work delves into the intricate processes of protein modifications such as ubiquitination, methylation, and phosphorylation, which are pivotal in understanding cellular functions and disease mechanisms. Dr. Rahimi's research is instrumental in unraveling the complexities of angiogenesis and tumor models. He employs a variety of mouse and cell culture-based approaches to explore these phenomena, contributing significantly to the understanding of cancer biology and therapeutic interventions. His investigations into the molecular pathways involved in cell signaling have the potential to inform the development of targeted treatments for various diseases. In addition to his research, Dr. Rahimi is committed to advancing the field through education and mentorship. He actively engages with students and colleagues, fostering a collaborative environment that encourages innovation and discovery. His contributions to the scientific community are reflected in his numerous publications and presentations at national and international conferences. Dr. Rahimi's work continues to push the boundaries of knowledge in pathology and laboratory medicine, with the ultimate goal of improving patient outcomes through scientific advancement.